Clinical Trial Update: Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part II [Phase 2]

View source ↗

Summary

A Phase 2 Part II study evaluating the safety of single doses of SAR113945 and the efficacy and safety of a new intra-articular formulation for knee osteoarthri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• SAR113945

Snippet

Sponsor: Sanofi | Conditions: Knee Osteoarthritis | Phase 2 | Status: COMPLETED